Eye Health Academy - Eye Health Academy

Eye Health Academy Hero

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Popular

The Fundingsland Group: Glaucoma Education
Evolving Strategies in Early- Stage Glaucoma Management
glaucomatoday.com
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast Replay
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD; Andrew G. Lee, MD
1.00 credit
- Prem S. Subramanian, MD, PhD
- Andrew G. Lee, MD
- Valerie Biousse, MD
1.00 credit
Retinal Vein Occlusion as a Marker of Systemic Risk
Retinal Vein Occlusion as a Marker of Systemic Risk
Eye on Ocular Health
Retinal Vein Occlusion as a Marker of Systemic Risk
Ashkan Abbey, MD
- Ashkan Abbey, MD
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Eye on Ocular Health
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Jessica Randolph, MD
- Jessica Randolph, MD
Catching Demodex in the Act
Catching Demodex in the Act
MinuteCE®
Catching Demodex in the Act
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
MinuteCE®
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
MinuteCE®
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
Closing the Loop: Structured Follow-Up and Patient Communication
Closing the Loop: Structured Follow-Up and Patient Communication
MinuteCE®
Closing the Loop: Structured Follow-Up and Patient Communication
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit

Clinical Practice

Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Eye on Ocular Health
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Akshay Thomas, M.D., M.S., FASRS
- Akshay Thomas, M.D., M.S., FASRS
EMPOWER - Contact Lens Success in Modern Optometric Clinics
EMPOWER - Contact Lens Success in Modern Optometric Clinics
Modern Optometry
EMPOWER - Contact Lens Success in Modern Optometric Clinics
Jacob Lang; Jaclyn Garlich
- Jacob Lang
- Jaclyn Garlich
- Melissa Barnett
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Ophthalmology
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Jordan Deaner; Vaidehi S. Dedania, MD
- Jordan Deaner
- Vaidehi S. Dedania, MD
- Rehan M. Hussain, MD
Daily Contact Lenses for New and Existing Patients
Daily Contact Lenses for New and Existing Patients
Modern Optometry
Daily Contact Lenses for New and Existing Patients
Jaclyn Garlich
- Jaclyn Garlich
Modernizing Diagnosis in Early-Stage Glaucoma
Modernizing Diagnosis in Early-Stage Glaucoma
The Fundingsland Group: Glaucoma Education
Modernizing Diagnosis in Early-Stage Glaucoma
Manjool Shah, MD; Inder Paul Singh
- Manjool Shah, MD
- Inder Paul Singh
- Zarmeena Vendal, MD
- Lorraine M. Provencher, MD
- Emily Schehlein, MD
- Swarup Swaminathan, MD
Trends in PDR Treatments
Trends in PDR Treatments
Ophthalmology
Trends in PDR Treatments
Maria H. Berrocal, MD; Katharine Talcott, MD
- Maria H. Berrocal, MD
- Katharine Talcott, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular Health
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
MH Risk Factors After RRD Repair
MH Risk Factors After RRD Repair
Ophthalmology
MH Risk Factors After RRD Repair
Maria H. Berrocal, MD; Avni P. Finn, MD, MBA
- Maria H. Berrocal, MD
- Avni P. Finn, MD, MBA